Feedback / Questions
MEM-288 - Memgen
https://www.globenewswire.com/news-release/2025/08/25/3138854/0/en/Memgen-Announces-First-Patient-Dosed-in-Phase-1-Combination-Cohort-of-MEM-288-Plus-Docetaxel-in-Advanced-Non-Small-Cell-Lung-Cancer.html
Aug 25, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next